Extend Biosciences Inc.
2 clinical trials · Sponsor
◉ Watch Extend Biosciences Inc.
| Record | Firm | Date |
|---|---|---|
| A Phase 2 Trial Investigating the Safety, Tolerability and Efficacy of EXT608 in Adults With Hypoparathyroidism (NCT06988670) | Extend Biosciences Inc. | 2025-05-05 |
| A Phase 1 Study of EXT608 in Healthy Adults (NCT05408663) | Extend Biosciences Inc. | 2022-07-21 |
Track Extend Biosciences Inc. automatically
Every clearance here is in the API, with alerts when new ones post.